BlackRock’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Buy
924,002
+504,362
+120% +$1.71M ﹤0.01% 4071
2026
Q1
$1.75M Sell
419,640
-6,927
-2% -$28.9K ﹤0.01% 4161
2025
Q4
$1.84M Buy
426,567
+154,791
+57% +$590K ﹤0.01% 4139
2025
Q3
$1.18M Buy
271,776
+2,103
+0.8% +$9.48K ﹤0.01% 4244
2025
Q2
$1.25M Buy
+269,673
New +$1.07M ﹤0.01% 4185

Other funds holding SBC

BlackRock's SBC Position: Q2 2026 in Review

BlackRock increased its SBC Medical Group (SBC) stake by 120% in Q2 2026, buying an estimated $1.71M and bringing the position to 924,002 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #4071.

BlackRock first reported a position in SBC in Q2 2025 and has held it in 5 quarters since. 57 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • BlackRock held 924,002 shares of SBC Medical Group worth $2.85M as of Q2 2026.
  • BlackRock bought 504,362 SBC Medical Group shares in Q2 2026, an estimated $1.71M.
  • SBC Medical Group made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4071 holding.
  • BlackRock first reported a position in SBC Medical Group in Q2 2025 and has held it in 5 quarters since.
  • 57 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.